Gemcitabine

Gemcitabine

Form: Lyophilized powder for solution for injection/infusion

Strength: 200 mg, 1000 mg, 1500 mg

Reference Brands: Gemzar® (US & EU)

Category: Oncology Cancer Care

Gemcitabine is a widely used oncology chemotherapy drug available in both the US and EU pharmaceutical B2B markets. Offered in 200 mg, 1 g, and 1.5 g vials, Gemcitabine comes as a lyophilized powder for intravenous infusion. Trusted by hospitals and oncology centers, it is essential for treating cancers such as pancreatic, lung, bladder, and breast cancer. Approved by the FDA and EMA, Gemcitabine is available through certified pharmaceutical wholesalers and B2B distributors across Europe and the United States. Buyers seeking reliable Gemcitabine suppliers can access competitive pricing, consistent quality, and regulatory-compliant sourcing for hospital and clinical use.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Atezolizumab

Strength: 1200 mg/20 mL

Form: Intravenous infusion

Reference Brands: Tecentriq® (EU & US)

View Details Get Enquiry
Durvalumab

Strength: 120 mg/4 mL, 500 mg/10 mL

Form: Injection

Reference Brands: Imfinzi® (US & EU)

View Details Get Enquiry
Sunitinib

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg

Form: Tablet

Reference Brands: Sutent® (EU & US)

View Details Get Enquiry
Ifosfamide

Strength: 1 g/vial,2 g/vial, 3 g/vial

Form: Injection

Reference Brands: Ifex® (US), Holoxan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience on our website. Learn more